Top Analyst Upgrades and Downgrades: Alcoa, Apple, Ciena, Cisco, Dave & Buster’s, GameStop, Hilton, Newmont Goldcorp, RH, Square, Zscaler and More

Print Email

Dave & Buster’s Entertainment Inc. (NASDAQ: PLAY) was up almost 3% at $43.72 ahead of earnings but was indicated down 15% at $37.20 afterward. William Blair downgraded it to Market Perform from Outperform. BMO Capital Markets maintained its Outperform rating but cut the target price to $50 from $555.

GameStop Corp. (NYSE: GME) was up 6.9% at $5.09 on Tuesday ahead of earnings but was indicated down 17% at $4.20 afterward. Wedbush maintained its Outperform rating and $8 target price based on cost cuts, buybacks and the upcoming console refresh cycle next year. Benchmark reiterated its Sell rating and lowered its price target to $3 from $5.

Hilton Worldwide Holdings Inc. (NYSE: HLT) was started with an Outperform rating and assigned a $108 target price at Bernstein. The stock closed at $93.58 ahead of the call and has a 52-week range of $63.76 to $101.14. Its prior consensus target price was $101.86.

J.B. Hunt Transport Services Inc. (NASDAQ: JBHT) was downgraded to Hold from Buy at Loop Capital. It closed up 2% at $116.24 ahead of the call, and its prior consensus target price was $106.33. The 52-week trading range is $83.64 to $126.99.

KLA Corp. (NASDAQ: KLAC) was reiterated as Buy and the price target was raised to $165 from $150 (versus a $148.75 prior close) at UBS. The consensus target price was $150.27 ahead of the call.

Navistar International Corp. (NYSE: NAV) was reiterated as Neutral and the target price was lowered to $32 from $34 at UBS. Shares closed at $28.77 ahead of the call and had a consensus target price of $34.91.

NetEase Inc. (NASDAQ: NTES) was named as the Bull of the Day at Zacks, which said that this stock lies at the intersection of gaming and the emerging Asian market. Shares of NetEase most recently closed at $272.72, with a consensus price target of $300.94.

Neurotrope Inc. (NASDAQ: NTRP) was downgraded to Neutral from Outperform and the target price was slashed to $1 from $13 at Janney. This is after the stock imploded this week after an Alzheimer’s disease study failed.

Newmont Goldcorp Corp. (NYSE: NEM) was raised to Outperform from Market Perform and its target price was raised to $50 from $45 (versus a $38.16 close) at BMO Capital Markets. It has a consensus target price of $45.86.

Prevail Therapeutics Inc. (NASDAQ: PRVL) was reiterated as Outperform with a $20 target price (versus a $9.09 close) at Wedbush. It is being targeted for a pediatric neuronopathic Gaucher disease that ultimately will be approved at the higher PR001 dose being deployed at an earlier stage.

RH (NYSE: RH), known as Restoration Hardware to the rest of us, was up 3.65% at $158.88 ahead of earnings and had traded up before last being seen down 2.2% at $155.15 after the report. Stifel reiterated its Buy rating and raised its target to $196 from $153, and Wells Fargo reiterated its Outperform rating and raised its target to $175 from $150. Merrill Lynch reiterated its Buy rating and raised its price objective to $175 from $165. Wedbush reiterated its Outperform rating and raised its target to $170 from $160.

Square Inc. (NYSE: SQ) was reiterated as Neutral but the price objective was lowered to $70 from $78 at Merrill Lynch. Square closed down 1.5% at $60.55 on Tuesday, and it had a prior consensus target price of $82.88.

T2 Biosystems Inc. (NASDAQ: TTOO) was reiterated as Neutral but its fair value estimate was raised to $2 (versus a $1.43 close) at Janney, with the firm talking up an unprecedented diagnostic government help from the Biomedical Advanced Research and Development Authority (BARDA) on its sepsis diagnostic test.

VF Corp. (NYSE: VFC) was reiterated as Neutral but the target was raised to $93 from $88 (versus an $89.82 close) at UBS.

Zscaler Inc. (NASDAQ: ZS) was down 0.7% at $61.60 ahead of earnings, but the high-beta shares were trading down 20% at $49.25 on Wednesday’s post-earnings reaction. Wedbush reiterated its Outperform rating with an $80 target price. The consensus target price was $80.56 at the start of the week, and it was $79.65 ahead of earnings. The 52-week trading range is $30.72 to $89.54.

Tuesday’s upgrades and downgrades included Ally Financial, Altria, AT&T, Ford, Micron Technology, Shopify, Valero Energy, Wells Fargo, Whiting Petroleum, Zscaler and many more.

I'm interested in the Newsletter